Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_assertion type Assertion NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_head.
- NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_assertion description "[The cysteine replacement of the highly conserved Y367 residue in fibroblast growth factor receptor 4 or the Q26X nonsense mutation in the tumor-suppressor kinase CSK are examples, and may contribute to cell line-specific signaling characteristics and tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_provenance.
- NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_assertion evidence source_evidence_literature NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_provenance.
- NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_assertion SIO_000772 18056464 NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_provenance.
- NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_assertion wasDerivedFrom befree-20150227 NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_provenance.
- NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_assertion wasGeneratedBy ECO_0000203 NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_provenance.